Global Corneal Pachymetry Market

Corneal Pachymetry Market Size, Share, Growth Analysis, By Method Type(Ultrasonic Method and Optical Method), By Application(Glaucoma Diagnosis and Refractive Surgery), By End User(Hospitals, clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35A2835 | Region: Global | Published Date: April, 2024
Pages: 217 | Tables: 86 | Figures: 71

Corneal Pachymetry Market News

  • In August 2022, the iStent Infinite is a trabecular micro-bypass system that Glaukos Corporation received FDA 510(k) clearance for. Its purpose is to lower intraocular pressure in individuals with primary open-angle glaucoma when other treatments have failed.
  • In October 2022, When Alcon acquired Ivantis, the company that developed the Hydrus Microstent, it was a big step forward. This novel gadget is intended to help reduce intraocular pressure in individuals with open-angle glaucoma, especially during cataract surgery. A USD 475 million down payment was required for the acquisition, and further payments might be made if certain legal and financial requirements were met.
  • In July 2023, The NT-1/1e Non-Contact Tonometer, a brand-new, cutting-edge gadget from Nidek, features an air-nozzle contact sensor for improved patient safety and automated measurements. By having patients place their chins on the chinrest, it streamlines the procedure and enables the device to detect eye position and start taking measures without the need for operator assistance. This development represents a significant step forward in safe and user-friendly eye care technologies.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Corneal Pachymetry Market size was valued at USD 397.2 billion in 2022 and is poised to grow from USD 420.5 billion in 2023 to USD 623.9 billion by 2031, growing at a CAGR of 5.8% in the forecast period (2024-2031).

A number of foreign companies are fighting for market dominance in the highly competitive corneal pchymetry industry. Due to their robust distribution networks and wide range of products, industry leaders Carl Zeiss Meditec AG, NIDEK CO., LTD., and Alcon, Inc. Furthermore, newcomers like Sonomed Escalon and Oculus Optikgeräte GmbH are stepping up the competition with cutting-edge pachymetry technologies that are meant to improve patient outcomes and increase diagnostic accuracy. 'DGH Technology Inc. (US)', 'EssilorLuxottica (France)', 'MEDA Co. Ltd. (China)', 'Quantel Medical (France)', 'CSO S.r. (India)', 'MicroMedical Devices Inc. (US)', 'Carl Zeiss AG (India)', 'Ophtec BV (Netherlands)', 'Escalon Medical Corp. (US)', 'Konan Medical Inc. (Japan)', 'Tomey Corporation (Japan)', 'Halma Plc (UK)', 'AMETEK Inc. (US)', 'NIDEK Co. Ltd. (Japan)', 'Glaukos Corporation (US)'

Growing awareness of a number of health issues together with better understanding of symptoms and medical illnesses due to improved internet availability. In the long run, the need for corneal pachymetry will likely be facilitated by the expanding efforts to encourage early detection of eye-related health concerns by healthcare practitioners. For example, in January 2023, scientists at GROW laboratory unveiled a diagnostic kit that may be used to identify, treat, and forecast keratoconus, ocular inflammation, dry eye, and other conditions.

Transformative Advances in Corneal Imaging: A big step forward has been made with the development of more objective diagnostic instruments and enhanced disease monitoring capabilities, which provide crucial direction for treatment choices. Systemic results are predicted, for example, when in vivo confocal microscopy is used for ocular subbasal nerve imaging. With the aid of this state-of-the-art technology, corneal diseases and structures can be visualized in detail, providing clinicians with a more precise and thorough understanding of corneal health. Improvements in diagnosis and the creation of more specialized treatment plans are made possible by these developments.

In 2023, the market was dominated by the North American region. The increased prevalence of glaucoma and refractive operations is the cause of the region's rise. The region's superior healthcare medication infrastructure is effectively propelling the growth of the corneal pachymetry market. The National Eye Institute projects that by 2030, there will be 4.2 million instances of glaucoma, a 58% increase in prevalence. In the years to come, this will increase the significance of corneal thickness medical testing in the area. The increasing prevalence of glaucoma patients, mostly in India, is predicted to fuel the region's rapid growth. In 2020, there were an estimated 76 million cases of glaucoma worldwide; India accounted for 20% of these instances. In the long run, there will likely be a high need for specific medical testing technologies, such as ocular pachymetry, due to the region's ageing population.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Hospital-Acquired Infection Control Market
Buy Now GET FREE SAMPLE
Capnography Market
Buy Now GET FREE SAMPLE
Test Strip Market
Buy Now GET FREE SAMPLE
Blood Glucose Monitoring System Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Corneal Pachymetry Market

Product ID: SQMIG35A2835

$5,300
BUY NOW GET FREE SAMPLE